Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human immunodeficiency virus 1 strain:HIV-1 CRF07_BC

ABSTRACT: Study of low-frequency drug-resistance variants in HIV-1 CRF07_BC isolates.

PROVIDER: PRJNA355609 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5069233.fastq.gz	Fastqsanger.gz
	SRR5069234.fastq.gz	Fastqsanger.gz
	SRR5069235.fastq.gz	Fastqsanger.gz
	SRR5069236.fastq.gz	Fastqsanger.gz
	SRR5069237.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 7

Similar Datasets

Human immunodeficiency virus 1

Project description:HIV low frequency drug resistance mutations on naive patients

| PRJNA209812 | ENA

Human immunodeficiency virus 1

Project description:Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure

| PRJNA230547 | ENA

Human immunodeficiency virus 1

Project description:HIV-1 Drug Resistance Genotyping of Reverse Transcriptase

| PRJNA743320 | ENA

Simian-Human immunodeficiency virus

Project description:Identification of drug- resistance mutations in majority and minority subpopulations of HIV-1 quasispecies

| PRJNA355237 | ENA

Ultra-deep sequencing of HIV populations

Project description:Identification of low-frequency variants in HIV populations using next-generation sequencing data

| PRJEB5053 | ENA

Post-transcriptional regulation of human immunodeficiency virus type-2 (HIV-2) replication by N6-methyladenosine

Project description:Human immunodeficiency virus type-2 (HIV-2) establishes reservoirs at levels comparable to HIV-1, but its infection is associated with lower rates of progression to AIDS. As such, a hallmark of people living with HIV-2 is the very low—usually undetectable—viral loads, which is partially explained by a post-transcriptional repression exerted at the level of protein synthesis and the accumulation of the full-length RNA in cytoplasmic granules. Here, we investigated whether HIV-2 Gag expression was regulated by the presence of the m6A RNA modification. Our results indicate that the HIV-2 full-length RNA contains m6A residues, which are required for Gag synthesis. Interestingly, the YTHDF family of cytoplasmic m6A readers exert different effects on HIV-2 Gag synthesis. As such, while YTHDF1 and YTHDF2 are necessary for Gag synthesis, YTHDF3 negatively regulates Gag expression by promoting full-length RNA localization in cytoplasmic granules. Interestingly, we demonstrate that the cellular m6A machinery including writers, erasers and readers re-localize into cytoplasmic granules together with the full-length RNA in a non-Gag producing cell sub-population. We also observed that FTO overexpression has no effect in Gag synthesis but promotes full-length RNA packaging suggesting a dynamic regulation of the cytoplasmic fate of this viral RNA. Together, these data suggest that the HIV-2 full-length RNA undergoes a complex regulation exerted by the cellular m6A machinery that controls the cytoplasmic localization, ribosome association and particle incorporation of this viral RNA.

2024-12-15 | GSE169556 | GEO

Human immunodeficiency virus 1

Project description:DTG Resist: HIV-1 subtype-specific drug resistance in people with virological failure on dolutegravir-containing antiretroviral therapy

| PRJNA1097829 | ENA

Complementation can maintain a quasispecies of drug sensitive and resistant HIV

Project description:The goal of this study was to determine how an HIV quasispecies is maintained in the face of selection. We deep sequenced the HIV provirus from cell populations as well as single cells at different time points from in vitro evolution experiments and found that when a less fit and more fit infect the same cell, they share components (complmentation) and therefore allow the less fit to perpetuate. We reproduced a quasispecies to an HIV reverse transcriptase inhibitor. The drug resistant genotype never completely supplanted the drug sensitive genotype, which stabilized at about 20% of viral sequences. Single-cell sequencing showed that resistant genotype frequency plateaued when cells were co-infected with sensitive and resistant genotypes, suggesting a sharing of viral proteins in co-infected cells (complementation), masking genotypic differences. To test if complementation can confer phenotypic drug resistance, we co-transfected fluorescently labelled molecular clones of sensitive and resistant HIV and observed drug resistance in genotypically sensitive virus from co-transfected cells. Resistant virus preferentially co-infected cells with drug sensitive HIV, explaining initiation of co-infections. Modelling showed that a stable quasispecies could form at the experimental multiplicities of infection. Conclusions: Complementation can lead to a quasispecies in infection environments where multiple infections per cell are common

2020-05-13 | GSE150390 | GEO

Human immunodeficiency virus 1

Project description:HIV-1 Envelope Clinical Isolates from Vicriviroc Resistant Subjects

| PRJNA317236 | ENA

Human immunodeficiency virus 1

Project description:Primer ID Sequencing of HIV-1 env gene to reveal X4 variants

| PRJNA314959 | ENA